Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508322 | SCV001714395 | uncertain significance | not provided | 2020-11-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002564239 | SCV003205449 | uncertain significance | Ataxia-telangiectasia syndrome | 2022-05-31 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1163345). This variant has not been reported in the literature in individuals affected with ATM-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 1132 of the ATM protein (p.Arg1132Lys). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ATM protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |